TABLE 2.
Microorganism | Community acquired (n=25) | Health care associated (n=35) | Nosocomial (n=17) | Total (n=77) |
---|---|---|---|---|
Third-generation cephalosporin-resistant organisms (n=15)
| ||||
2/25 (8%) | 6/35 (17%) | 7/17 (41%) | – | |
Viridans group Streptococci | 1 | 0 | 0 | 1 |
Enterococcus | 0 | 2 | 3 | 5 |
Vancomycin-resistant enterococcus | 0 | 0 | 1 | 1 |
Enterobacter | 0 | 2 | 2 | 4 |
ESBL Escherichia coli | 0 | 2 | 1 | 3 |
Bacteroides | 1 | 0 | 0 | 1 |
Third-generation cephalosporin-sensitive organisms (n=62)
| ||||
23/25 (92%) | 29/35 (83%) | 10/17 (59%) | – | |
Streptococcus | 15 | 14 | 6 | 35 |
Staphylococcus aureus | 1 | 0 | 1 | 2 |
Escherichia coli | 3 | 12 | 2 | 17 |
Klebsiella | 4 | 2 | 1 | 7 |
Pseudomonas | 0 | 1 | 0 | 1 |
ESBL Extended-spectrum beta-lactamase